Shanghai Pharmaceuticals Holding Co., Ltd. (announcement dated 31 March 2026) declared a final ordinary cash dividend of RMB3.50 for every 10 shares for the financial year ended 31 December 2025, subject to shareholder approval at a forthcoming general meeting (date to be announced).
The dividend will be distributed to holders of H shares through Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Details on the default payment currency, applicable exchange rate, ex-dividend date, record date, latest time for share transfer lodgement, and payment date will be confirmed in subsequent notices.
Withholding tax arrangements: • Resident enterprise shareholders (registered in the PRC) – 10% enterprise income tax will be withheld. • Non-resident individual shareholders whose domicile countries have a treaty rate of 10% or below – 10% individual income tax will be withheld. • Non-resident individual shareholders whose domicile countries have a treaty rate above 20% or no treaty – 20% individual income tax will be withheld. • Mainland individual investors holding H shares through Southbound Trading – 20% individual income tax will be withheld.
No warrants or convertible securities are affected by this dividend declaration.
Board composition at the time of announcement: Executive Directors – Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming; Non-executive Director – Zhang Wenxue; Employee Director – Zhao Yong; Independent Non-executive Directors – Gu Zhaoyang, Fok Manson, Wang Zhong, Man Kwan.
Comments